PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF AN INITIALLY INTENSIFIED DOSING REGIMEN VERSUS A STANDARD DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT PATIENTS.: 717

@article{Budde2008PHARMACOKINETICAP,
  title={PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF AN INITIALLY INTENSIFIED DOSING REGIMEN VERSUS A STANDARD DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT PATIENTS.: 717},
  author={Klemens Budde and Wolfgang W Arns and Petra Glander and Claudia Sommerer and Toofan Ariatabar and Stefanie Kramer and Karin Eichele and Wolfgang H Fischer and Martin Zeier},
  journal={Transplantation},
  year={2008},
  volume={86},
  pages={251}
}
Enteric-Coated Mycophenolate Sodium
TLDR
In randomized, double-blind trials of de novo and maintenance immunosuppressive therapy in renal transplant patients receiving ciclosporin emulsion-based regimens, enteric-coated mycophenolate sodium was as effective as myCophenolate mofetil in preventing renal graft rejection. Expand
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
TLDR
The goal of this consensus meeting was to offer information to transplant practitioners on clinically relevant pharmacokinetic characteristics of MPA, to rationalize the basis for currently advised target exposure ranges for MPA in various types of organ transplantation, and to summarize available methods for application of M PA TDM in clinical practice. Expand
Immunotherapy in Elderly Transplant Recipients
TLDR
Important drug interactions between immunosuppressant drugs have been identified and require attention when choosing an appropriate immunosppressant drug regimen for the frail elderly organ recipient. Expand
New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation
TLDR
New insights for the calcineurin inhibitors (CNIs) cyclosporine and tacrolimus and the antimetabolite mycophenolic acid (MPA) are highlighted and the possible consequences are discussed. Expand
This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Immunotherapy in Elderly Transplant Recipients Guide to Clinically Significant Drug Interactions
Currently, >50% of candidates for solid organ transplantation in Europe and the US are aged >50 years while approximately 15% of potential recipients are aged ‡65 years. Elderly transplant candidatesExpand